Allopurinol sodium
- Level
- Commodity
- Parent
- 51192000
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51192019This classification denotes a xanthine oxidase inhibitor and uricosuric agen with the molecular formula C5H3N4O.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 428673RC2Z, chemically known as 1,5-dihydro-4h-pyrazolo(3,4-d)pyrimidine-4-one but more generally known as allopurinol sodium, which bears US NIH Compound Identifier 2094. The base compound, Allopurinol, comes in other forms, including di-methyl, ribonucleoside, riboside, riboside, and 5-monophosphate. European Medicines Agency schedules Allopurinol sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30291. Most nations, for tariff and trade purposes, schedule allopurinol sodium under HS 29335995 and SITC 51576. As of Q4 2014, ALLOPURINOL SODIUM remains US FDA's Preferred Term for this commodity. Allopurinol sodium bears US NLM identifiers UMLS ID C0278766 and NCI Concept Code C2564. SMILES: C1C2C(=O)[NH]CNC2[N-]N1.[NA+].
Same parent
Under 51192000 · 21Activities that produce or sell this
KBLI · 9Inherited from family 51190000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.